Role of CD71 in acute leukemia– An immunophenotypic marker for erythroid lineage or proliferation? | Zendy

PoojaSharma Kala | Zendy; Seema Acharya | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Role of CD71 in acute leukemia– An immunophenotypic marker for erythroid lineage or proliferation?

Author(s) -

PoojaSharma Kala,

Seema Acharya

Publication year - 2019

Publication title -

indian journal of pathology and microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.217

H-Index - 31

eISSN - 0974-5130

pISSN - 0377-4929

DOI - 10.4103/ijpm.ijpm_604_18

Subject(s) - lymphoblast , transferrin receptor , leukemia , myeloid leukemia , acute promyelocytic leukemia , myeloid , acute leukemia , immunology , immunophenotyping , bone marrow , medicine , biology , cancer research , transferrin , antigen , cell culture , genetics , retinoic acid

Hepatitis C virus (HCV) is characterized by a high degree of nucleotide sequence variability between genotypes. This variability extends to functional and immunological determinants. Serological tests using antigenic segments derived from the HCV polyprotein have been used for the diagnosis of HCV infection. However, available diagnostic Kits do not necessarily take type variability into consideration and are not optimized for HCV genotype 4a (HCV 4a ), the predominant genotype in Egypt.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research